Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis

Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis

Abstract Fibrotic diseases cause organ failure that lead to ~45% of all deaths in the United States. Activated macrophages stimulate fibrosis by secreting cytokines that induce fibroblasts to synthesize collagen and extracellular matrix proteins. Although suppression of macrophage‐derived cytokine p...

Descrición completa

Detalles Bibliográficos
Main Authors: Fenghua Zhang, Ehab A Ayaub, Bingbing Wang, Estela Puchulu‐Campanella, Yen‐Hsing Li, Suraj U Hettiarachchi, Spencer D Lindeman, Qian Luo, Sasmita Rout, Madduri Srinivasarao, Abigail Cox, Konstantin Tsoyi, Cheryl Nickerson‐Nutter, Ivan O Rosas, Philip S Low
Formato: Artigo
Idioma:English
Publicado: Springer Nature 2020-06-01
Series:EMBO Molecular Medicine
Subjects:
bleomycin
folate receptor β
idiopathic pulmonary fibrosis
macrophages
toll‐like receptor 7
Acceso en liña:https://doi.org/10.15252/emmm.202012034

Internet

https://doi.org/10.15252/emmm.202012034

Títulos similares